Human pharmaceuticals for the treatment of infectious-related disease, auto-immune and inflammatory diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases, muscle dystonias, smooth muscle disorders, gastro-intestinal diseases; human pharmaceuticals for use as hemostatic agents